약제 용출형 풍선 카테터 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Drug-eluting Balloon Catheters Market size is expected to reach USD 2.69 Billion in 2034 from USD 1.22 Billion (2025) growing at a CAGR of 9.16% during 2026-2034.

The Global Drug-eluting Balloon Catheters Market is witnessing steady growth due to the rising prevalence of cardiovascular diseases and increasing demand for minimally invasive procedures. These catheters are widely used in treating coronary and peripheral artery diseases, as they deliver medication directly to the arterial wall while reducing the risk of restenosis. Growing awareness among patients and physicians about advanced interventional techniques is further contributing to market expansion.

Key drivers include the aging global population, unhealthy lifestyles leading to heart disorders, and technological advancements in catheter design. Hospitals and specialty cardiac centers are increasingly adopting drug-eluting balloon technologies because they offer shorter recovery times and fewer complications compared to traditional stents. Continuous research and development activities by medical device companies are also enhancing product performance and safety profiles.

Looking ahead, the market is expected to benefit from improved healthcare infrastructure in emerging economies and expanding reimbursement coverage for interventional cardiology procedures. Innovation in drug formulations and combination therapies will likely strengthen clinical outcomes. As demand for minimally invasive treatments continues to rise globally, drug-eluting balloon catheters are projected to remain an important solution in vascular disease management.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Paclitaxel Drug-Eluting Balloon Catheters
• Sirolimus Drug-Eluting Balloon Catheters

By Indication

• Coronary Intervention
• Peripheral Intervention

By End User

• Hospitals and ASCs
• Catheterization Laboratories
• Others

COMPANIES PROFILED

• Becton Dickinson and Company, , Meril Life Sciences Pvt Ltd, Medtronic, Eurocor Tech GmbH, Zhejiang Barty Medical Technology Co Ltd, Biotronik, iVascular, Lepu Medical Technology Beijing Co Ltd, Concept Medical, Koninklijke Philips NV
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DRUG-ELUTING BALLOON CATHETERS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Paclitaxel Drug-Eluting Balloon Catheters Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Sirolimus Drug-Eluting Balloon Catheters Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DRUG-ELUTING BALLOON CATHETERS MARKET: BY INDICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Indication
• 5.2. Coronary Intervention Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Peripheral Intervention Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DRUG-ELUTING BALLOON CATHETERS MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals and ASCs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Catheterization Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DRUG-ELUTING BALLOON CATHETERS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Indication
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Indication
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Indication
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Indication
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Indication
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL DRUG-ELUTING BALLOON CATHETERS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Meril Life Sciences Pvt. Ltd
  • 9.2.2 Medtronic
  • 9.2.3 Eurocor Tech GmbH
  • 9.2.4 Zhejiang Barty Medical Technology Co. Ltd
  • 9.2.5 Biotronik
  • 9.2.6 IVascular
  • 9.2.7 Lepu Medical Technology (Beijing) Co. Ltd
  • 9.2.8 Concept Medical
  • 9.2.9 Koninklijke Philips N.V